Bioventus makes pain treatment and surgical products for musculoskeletal care, sold to physicians, surgeons and hospitals. It last closed at $9.88 on Nov 20, down 0.70% on the day. The next earnings report for BVS is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, BVS reported EPS of $0.08 on revenue of $142.4M, with revenue up 2.7% from a year ago. Over its last 8 reports the stock moved an average of 13.6% the session after earnings. Over the last 12 months BVS insiders bought $0 of stock on the open market and sold $181K, according to SEC Form 4 filings.
AI Auto Pilots
Is BVS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BVS.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on BVSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
BVS · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold
The stock is 19% below its 20 day and 30% below its 50 day average. It is 13% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 29), oversold. The nearest support is the Pivot S1 at $9.74, and the nearest resistance the Pivot at $9.95.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 6.4%/day
Key levels
$15.8952 week high+60.8%
$12.99100 day average+31.5%
$12.8150 day average+29.7%
$12.30Swing high (Jul 9)+24.5%
$11.7520 day average+18.9%
$11.12200 day average+12.6%
$10.10Pivot R1+2.2%
$9.95Pivot+0.7%
$9.88Last close
$9.74Pivot S1−1.4%
$9.28Swing low (Jun 30)−6.1%
$6.4752 week low−34.5%
Indicators
RSI (14)
28.91
Oversold below 30
Oversold
MACD
-0.89
Below its signal line
Bearish
Stochastic
5.2
Near the bottom of its range
Oversold
ADX (14)
30.8
Trending down
Williams %R
-96.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-82.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.9%
Change over 10 sessions
Bearish
ATR (14)
$0.63
Typical daily range, 6.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 13.9%/day
Key levels
$15.8952 week high+60.8%
$12.99100 day average+31.5%
$12.8150 day average+29.7%
$12.30Swing high (Jul 9)+24.5%
$11.7520 day average+18.9%
$11.12200 day average+12.6%
$10.10Pivot R1+2.2%
$9.95Pivot+0.7%
$9.88Last close
$9.74Pivot S1−1.4%
$9.28Swing low (Jun 30)−6.1%
$6.4752 week low−34.5%
Indicators
RSI (14)
39.96
Weak, oversold below 30
Neutral
MACD
0.27
Below its signal line
Bearish
Stochastic
7.0
Near the bottom of its range
Oversold
ADX (14)
40.2
Strong downtrend
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-178.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−23.9%
Change over 10 sessions
Bearish
ATR (14)
$1.37
Typical daily range, 13.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for BVS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BVS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow BVS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for BVSHow many large options trades hit BVS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in BVS in the last 90 days.
From SEC Form 4 filings by BVS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BVS is in one of them and how their past BVS trades turned out.
Bioventus is a medical device company based in Durham, North Carolina. It makes products that relieve pain and treat musculoskeletal conditions, including hyaluronic acid knee injections, implantable nerve stimulation systems for chronic pain, and ultrasonic bone cutting tools used in spine and neurosurgery. The company also offers bone graft substitutes that support bone fusion and a device that uses low intensity pulse ultrasound to help fractures heal. Its customers include physicians and surgeons, along with the hospitals, clinics and ambulatory surgical centers where patients are treated.